research strategy development and application. Here, we aim to tap into and share resources, such as biobanking and data generation, possibly through the One Zone, Two Parks arrangement at the Lok Ma Chau Loop. The third is about human resources development and strategy. We plan to establish an International Clinical Research Academy that will train research and clinical professionals who can conduct and support clinical trials. Finally, the fourth dimension centres on global communications and engagement. We will set up a communication and exchange platform with government and research bodies in the GBA, establish an Asian Clinical Research Consortium, and participate in global networks and engage with industry at all levels. There is a lot of work for us to do, but we are well-prepared for it thanks to the experience of our Clinical Trials Centre. With the GBAICTI, we are very excited by the prospect that within the next three to five years, HKUMed will make substantial contributions to the GBA’s development as a regional and national hub for biomedical innovation and translation. On top of that great news, we are looking ahead to even more opportunities for external engagement. The Hong Kong government plans to invest HK$6 billion in Life and Health Technology Research Institutes – LHTRIs – that are multidisciplinary and cross-institutional. The aims are very much in line with the School of Biomedical Engineering in wanting to bring diverse but relevant parties together to propel innovation. HKUMed has already identified local institutional partners, and we are working hard to develop a proposal to become one of the initial LHTRIs. I will keep you posted on our progress. 4
RkJQdWJsaXNoZXIy Mzg4NDg0